| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/26/1997 | CA2241004A1 Compositions for modulating intracellular inositol trisphosphate concentration and uses thereof |
| 06/26/1997 | CA2240835A1 Piperazine derivatives as tachykinin antagonists |
| 06/26/1997 | CA2240729A1 Use of a medicament and use of mixture of substances to produce a medicament |
| 06/26/1997 | CA2240449A1 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | CA2240366A1 New phospholipid derivatives of phosphonocarboxylic acids, the production thereof as well as their use as antiviral pharmaceutical agents |
| 06/26/1997 | CA2240365A1 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments |
| 06/26/1997 | CA2240139A1 Pge-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction |
| 06/26/1997 | CA2240131A1 Composition for organ cryopreservation and treatment of viral and bacterial infections |
| 06/26/1997 | CA2239487A1 Novel method |
| 06/26/1997 | CA2239126A1 Tgf.beta. signal transduction proteins, genes, and uses related thereto |
| 06/26/1997 | CA2193751A1 Treatment and prophylaxis of osteoporosis |
| 06/26/1997 | CA2193578A1 Multidrug resistance inhibitors |
| 06/26/1997 | CA2187128A1 New and useful polymorph of anhydrous paroxetine hydrochloride |
| 06/25/1997 | EP0780475A1 CDNA corresponding to the genome of negative-strand RNA viruses, and process for the production of infectious negative-strand RNA viruses |
| 06/25/1997 | EP0780397A2 New 17alpha-Cyanomethylestra-4,9-dien-derivatives, a process for the production of these compounds and pharmaceutical compositions containing them |
| 06/25/1997 | EP0780393A1 Novel crystal of cephalosporin compound |
| 06/25/1997 | EP0780390A1 Crystalline modification of CDCH, process for its preparation and pharmaceutical compositions containing it |
| 06/25/1997 | EP0780389A1 Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them |
| 06/25/1997 | EP0780388A1 5HT1Dalpha and 5HT2A ligands |
| 06/25/1997 | EP0780387A1 Thiophene compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/25/1997 | EP0780386A1 Matrix metalloprotease inhibitors |
| 06/25/1997 | EP0780379A1 A 4-imidazolidinone derivative and its use as NMDA receptor agonist |
| 06/25/1997 | EP0780369A1 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol derivatives as pharmaceutical agents |
| 06/25/1997 | EP0780129A2 Adrenal cortical steroid containing external therapeutic composition for dermatitis |
| 06/25/1997 | EP0780128A2 Crotonic acid amide derivatives and lipoprotein containing compositions |
| 06/25/1997 | EP0780127A1 A nasal spray containing a steroid and a antihistamine |
| 06/25/1997 | EP0780125A2 Pharmaceutical composition containing a hydantoin derivative and use of said derivative |
| 06/25/1997 | EP0780124A1 Pharmaceutical composition comprising L-carnitine or an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders |
| 06/25/1997 | EP0780123A1 Beta-hydroxybutyric acid or acetoacetic acid or salts or esters therof for use in improving cerebral function |
| 06/25/1997 | EP0780122A1 Depressant of functions developed by molecule |
| 06/25/1997 | EP0780121A1 Eye lotion in particular for dry eye treatment |
| 06/25/1997 | EP0780120A1 Use of procysteine as skin whitening agent |
| 06/25/1997 | EP0780055A2 Nutritional coffee composition |
| 06/25/1997 | EP0779893A2 Oligonucleotide prodrugs |
| 06/25/1997 | EP0779889A1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE |
| 06/25/1997 | EP0779888A1 Pyrimido [5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them |
| 06/25/1997 | EP0779885A1 Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring |
| 06/25/1997 | EP0779820A1 Bioadhesive-wound healing composition |
| 06/25/1997 | EP0779819A1 Therapeutic treatment of clostridium difficile associated diseases |
| 06/25/1997 | EP0779814A1 Antithrombotic and non-hemorrhagic heparin-based compositions, method for their preparation and therapeutic applications |
| 06/25/1997 | EP0779813A1 Phosphonates and parathyroid hormone for osteoporosis |
| 06/25/1997 | EP0779812A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
| 06/25/1997 | EP0779811A1 Myocardial protection using benzothiazepinones |
| 06/25/1997 | EP0779810A1 Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes |
| 06/25/1997 | EP0779809A1 Use of selegiline to prolong life span |
| 06/25/1997 | EP0779808A1 Triphenylethylenes for the prevention and treatment of osteoporosis |
| 06/25/1997 | EP0723444B1 Levobupivacaine useful for managing chronic pain |
| 06/25/1997 | EP0707478A4 Improved nicotine lozenge and therapeutic method for smoking cessation |
| 06/25/1997 | EP0706376B1 Anti-angiogenic compositions and methods of use |
| 06/25/1997 | EP0693874A4 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 06/25/1997 | EP0690904B1 Unsaponifiable materials of vegetable origin and cosmetic compositions containing same |
| 06/25/1997 | EP0656886B1 N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors |
| 06/25/1997 | EP0581844B1 Process for producing pvp-h2o2 products |
| 06/25/1997 | EP0538486B1 Sewing machine needle and method of manufacturing same |
| 06/25/1997 | CN1152937A Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 06/25/1997 | CN1152921A Pyrido £3,2,1-i,j|£3,1| benzoxazine derivatives |
| 06/25/1997 | CN1152920A Palladium catalyzed ring closure of triazolyl tryptamine |
| 06/25/1997 | CN1152919A Triazole compounds and their use as dopamine-D3-ligands |
| 06/25/1997 | CN1152918A Novel amido quinoxaline diones, their production and use |
| 06/25/1997 | CN1152917A Substituted pryimidine compounds and their use |
| 06/25/1997 | CN1152916A Trifluoromethylquinoline carboxylic acid derivative |
| 06/25/1997 | CN1152915A Quinoline derivatives as leukotriene antagonists |
| 06/25/1997 | CN1152910A Difluorostatone antiviral agents |
| 06/25/1997 | CN1152879A Conjugates made of metal complexes and oligonucleotides |
| 06/25/1997 | CN1152874A Copolymer-1 improvements in compositions of copolymers |
| 06/25/1997 | CN1152873A New pharmaceutical preparationf or pain management |
| 06/25/1997 | CN1152872A Use of thiazole and thiadiazole compounds as D3 dopamine receptor ligands |
| 06/25/1997 | CN1152871A Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor |
| 06/25/1997 | CN1152870A Use of heterocyclic compounds as dopamines-D3 ligands |
| 06/25/1997 | CN1152869A Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 06/25/1997 | CN1152868A Use of droloxidfene for the treatment of cardiovascular diseases |
| 06/25/1997 | CN1152866A Soap composition |
| 06/25/1997 | CN1152865A Methods of lightening hyperpigmented regions in mammalian skin |
| 06/25/1997 | CN1152578A Isomerisation of equilin |
| 06/25/1997 | CN1152575A New cephalosporing containing in position 7 substituted benzyloxyimino radical, their preparation process and intermediates, their use as medicaments |
| 06/25/1997 | CN1152574A Crystalline hydrochloride of (R)-(-)2{N-4£4-(1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl|-aminomethyl}-chroman |
| 06/25/1997 | CN1152573A Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients |
| 06/25/1997 | CN1152572A New heterocyclic tertiary amines, process for their preparation and pharmaceutical compositions containing them |
| 06/25/1997 | CN1152468A Slow releasing composition |
| 06/25/1997 | CN1152435A Medicinal products containing antimer pure beta-D-dioxypentacyclic nucleoside |
| 06/25/1997 | CN1152434A Oral preparation of S(+)1,8-diethyl-1,3,4,9-tetrahydropyrano (3,4-b) indole-1-acetic acid |
| 06/25/1997 | CN1152433A Method for preparation of porphyrin iron powder |
| 06/25/1997 | CN1152432A Kouyankang atomized agent for mouth and throat |
| 06/25/1997 | CN1152431A Dry syrup of teldane |
| 06/25/1997 | CN1035255C Heterotricyclic derivatives |
| 06/25/1997 | CN1035232C method for prodn. of medicinal prepns. for eyes |
| 06/24/1997 | US5641889 Therapeutic nucleosides |
| 06/24/1997 | US5641886 Process for preparation of N-tert.butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-phthalimidobutyl]-(4AS,8AS)-isoquinoline-3(S)-carboxamide |
| 06/24/1997 | US5641875 Dna construct encoding immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cell comprising same |
| 06/24/1997 | US5641863 Immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cells comprising same |
| 06/24/1997 | US5641814 Antikeratolytic-wound healing compositions and methods for preparing and using same |
| 06/24/1997 | US5641813 Layered double hydroxide and-or hydroxy salt |
| 06/24/1997 | US5641810 Use of α, ω-dicarboxylic acids as fibrinogen sinkers |
| 06/24/1997 | US5641809 Treatment of adverse skin reactions in radiation therapy |
| 06/24/1997 | US5641807 Administering 3-amino-5-carbamoylchromans |
| 06/24/1997 | US5641805 Topical ophthalmic formulations for treating allergic eye diseases |
| 06/24/1997 | US5641803 Injecting regulated dosages over a shorter time period causes less myelosuppression and hematologic toxicity |
| 06/24/1997 | US5641801 Method of reducing the period before the onset of sleep |
| 06/24/1997 | US5641800 Alleviate effect of septic shock, adult respiratory distress syndrome, pancreatitis, trauma, bronchial asthma, allergic rhinitis, and rheumatoid arthritis |
| 06/24/1997 | US5641798 Bicyclic compounds and their use as excitatory amino acid receptor antagonists |